ABCA4相关视网膜病变进展:人口学、功能、遗传与影像参数的预后价值
结果显示年均萎缩进展为0.89 mm,萎缩区数量、全视网膜功能损害和发病年龄类别是显著预测因子,可解释25.7%的变异。基于这些基线特征进行患者预选或延长模拟研究时长,可显著减少所需样本量。
要点
- ABCA4相关视网膜病变视网膜色素上皮萎缩年均进展为0.89 mm。
- 萎缩区数量、全视网膜功能损害和发病年龄类别可预测萎缩增长。
- 基于基线特征预选患者或调整试验时长可减少模拟试验所需样本量。
核心结论
- 特定形态描述因素和患者基线特征对ABCA4相关视网膜病变的视网膜色素上皮萎缩进展具有预后价值。
- 基于基线特征预选患者或调整试验时长,可在模拟干预研究中显著减少所需样本量和绝对访视次数。
研究设计与样本
- 采用眼底自发荧光成像纵向检查,测定 definitely decreased autofluorescence 区域的面积、周长、圆度、卡尺直径和灶性。
- 使用模型基于基线变量预测病灶扩大率,并进行样本量计算以模拟干预研究的检验效能。
主要发现
- 视网膜色素上皮萎缩的年均进展为0.89 mm。
- 萎缩区数量、全视网膜功能损害和发病年龄类别是未来视网膜色素上皮萎缩增长的显著预测因子,共同解释25.7%的变异性。
关键数值与推荐
- 视网膜色素上皮萎缩年均进展为0.89 mm。
- 萎缩区数量、全视网膜功能损害和发病年龄类别共同解释25.7%的变异性。
临床怎么用
- 在ABCA4相关视网膜病变的临床试验设计中,可考虑基于萎缩区数量、全视网膜功能损害和发病年龄类别进行患者预选。
- 可考虑调整试验时长以优化所需样本量和访视次数。
局限性
- 随访时间范围为10至100个月,存在差异。
- 预测模型仅解释25.7%的变异性,提示其他因素未纳入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the prognostic value of demographic, functional, genetic, and imaging parameters on retinal pigment epithelium atrophy progression secondary to ABCA4-related retinopathy. METHODS: Patients with retinal pigment epithelium atrophy secondary to ABCA4-related retinopathy were examined longitudinally with fundus autofluorescence imaging. Lesion area, perimeter, circularity, caliper diameters, and focality of areas with definitely decreased autofluorescence were determined. A model was used to predict the lesion enlargement rate based on baseline variables. Sample size calculations were performed to model the power in a simulated interventional study. RESULTS: Sixty-eight eyes of 37 patients (age range, 14-78 years) with a follow-up time of 10 to 100 months were included. The mean annual progression of retinal pigment epithelium atrophy was 0.89 mm. The number of atrophic areas, the retina-wide functional impairment, and the age-of-onset category constituted significant predictors for future retinal pigment epithelium atrophy growth, explaining 25.7% of the variability. By extension of a simulated study length and/or specific patient preselection based on these baseline characteristics, the required sample size could significantly be reduced. CONCLUSION: Trial design based on specific shape-descriptive factors and patients' baseline characteristics and the adaption of the trial duration may provide potential benefits in required cohort size and absolute number of visits.
引用
- Müller PL, Pfau M, Treis T, et al. PROGRESSION OF ABCA4-RELATED RETINOPATHY: Prognostic value of demographic, functional, genetic, and imaging parameters. Retina. 2020. PMID: 33214501. doi:10.1097/IAE.0000000000002747
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。